BeiGene, Ltd.
USPTO PatentsView assignee record - 50 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Beigene ranks #6,625 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 10 technology areas.
- #6,625
- of 49,997 US assignees by volume
- Top 26%
- by Innovation Score (44.2/100)
- 20.5
- avg claims per patent
- +24%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6625 · Foreign Corporation #6,625 · 50 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 50 grants
- UPPER-Q #6,625/49,997
- PHOTO-FINISH Alentic Microscience
- CPC-FOCUS A61P · 10 areas
- INNOV-PAR 44.2/100
- CLAIMS-DENSE 20.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +24% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Alentic Microscience Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Beigene’s 44.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Beigene
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Agenus · near
Agenus · near
44 score
- BeiGene · this assignee
BeiGene · this assignee
44 score
- Genethon · near
Genethon · near
44 score
- MTS Systems · near
MTS Systems · near
44 score
- Sequenom · near
Sequenom · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Beigene's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Beigene?
Each dot is one of Beigene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Beigene’s own 20.5 claims/patent is ABOVE the 17.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Beigene's grants concentrate
BeiGene, Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 92% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (8 grants) versus a trough of 1 in 2015. By volume, Beigene sits between Alentic Microscience Inc. and Chdi Foundation, Inc..
Beigene's three-year grant acceleration
BeiGene, Ltd. shows 16 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at BeiGene's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Alentic Microscie…
Alentic Microscience Inc.
50 patents
- Altor Bioscience
Altor Bioscience LLC
50 patents
- Beijing Youzhuju…
Beijing Youzhuju Network Technology Co., Ltd.
50 patents
- Barrette Outdoor…
Barrette Outdoor Living, Inc.
50 patents
- Bradford
Bradford Company
50 patents
- British Columbia…
British Columbia Cancer Agency Branch
50 patents
- Central Garden &…
Central Garden & PET Company
50 patents
- Chdi Foundation
Chdi Foundation, Inc.
50 patents
- Beigene ◀
BeiGene, Ltd.
50 patents
What this shows BeiGene holds 50 patents at rank #6,626, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near BeiGene
By rank, the assignees closest to #6,626 in granted patent volume.
- Alentic Microscience Inc. #6,622 · 50 patents
- Altor Bioscience LLC #6,623 · 50 patents
- Beijing Youzhuju Network Technology Co., Ltd. #6,624 · 50 patents
- Barrette Outdoor Living, Inc. #6,625 · 50 patents
- Bradford Company #6,627 · 50 patents
- British Columbia Cancer Agency Branch #6,628 · 50 patents
- Central Garden & PET Company #6,629 · 50 patents
- Chdi Foundation, Inc. #6,630 · 50 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in BeiGene's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for BeiGene, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), BeiGene ranks #394 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Similar claim depth
Nearest assignees by average claims per patent (20.5 here).
Beigene's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 2.0% |
| 2016 | 5 | 10.0% |
| 2017 | 6 | 12.0% |
| 2018 | 4 | 8.0% |
| 2019 | 5 | 10.0% |
| 2020 | 5 | 10.0% |
| 2021 | 5 | 10.0% |
| 2022 | 8 | 16.0% |
| 2023 | 4 | 8.0% |
| 2024 | 4 | 8.0% |
| 2025partial year | 3 | 6.0% |
Which technologies does BeiGene, Ltd. patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
BeiGene, Ltd.'s patent record in context - here's where to go next.
- BeiGene, Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 92% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #6,625 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare BeiGene, Ltd. against Alentic Microscience Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.